Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Operating Income of -$2.54 million for fiscal year 2025.
HERON THERAPEUTICS, INC. /DE/ Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$2.54M | +78.0% |
| 2024 | -$11.53M | +89.6% |
| 2023 | -$110.61M | +36.7% |
| 2022 | -$174.66M | +19.8% |
| 2021 | -$217.83M | +4.5% |
| 2020 | -$228.16M | -8.3% |
| 2019 | -$210.69M | -14.5% |
| 2018 | -$183.94M | +5.5% |
| 2017 | -$194.56M | -13.8% |
| 2016 | -$170.91M | -76.3% |
| 2015 | -$96.92M | -30.0% |
| 2014 | -$74.56M | -36.9% |
| 2013 | -$54.46M | -128.5% |
| 2012 | -$23.83M | -115.4% |
| 2011 | -$11.06M | -11.4% |
| 2010 | -$9.93M | +3.0% |
| 2009 | -$10.24M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.09M | +8.2% | -150.0% |
| June 30, 2025 | -$1.64M | +74.6% | -151.9% |
| March 31, 2025 | $3.15M | +165.7% | +170.7% |
| September 30, 2024 | -$4.46M | +82.1% | +30.8% |
| June 30, 2024 | -$6.45M | +84.8% | -34.3% |
| March 31, 2024 | -$4.80M | +85.5% | +80.8% |
| September 30, 2023 | -$24.93M | +40.5% | +41.2% |
| June 30, 2023 | -$42.40M | +14.3% | -28.2% |
- HERON THERAPEUTICS, INC. /DE/ showed an increase of +78.0% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, HERON THERAPEUTICS, INC. /DE/’s operating income has grown by 75.2% (from -$10.24 million to -$2.54 million).
- The most recent figure is from HERON THERAPEUTICS, INC. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: